Spain Rebecca I, Mancini Martina, Horak Fay B, Bourdette Dennis
Neurology Service and MS Center of Excellence-West, Portland VA Medical Center, USA; Department of Neurology, Oregon Health & Science University, USA.
Department of Neurology, Oregon Health & Science University, USA.
Gait Posture. 2014 Mar;39(3):958-64. doi: 10.1016/j.gaitpost.2013.12.010. Epub 2013 Dec 21.
Gait and balance deficits are a frequent complaint in MS but poorly captured by stopwatch-timed tests or rating scales. Body-worn accelerometers and gyroscopes are able to detect gait and balance abnormalities in people with MS who have normal walking speeds. Few longitudinal studies exist using this technology to study the evolution of mobility deficits. The purpose of this study was to determine if body-worn sensors detected any decline in gait and balance measures in people with MS over time. Twenty-seven people with MS (13 mildly disabled, self-rated expanded disability status scale 0-3.5; 14 moderately disabled, SR-EDSS 4.0-5.5) who had normal walking speeds and 18 matched control subjects underwent gait and balance testing using body-worn sensors every 6 months for 18 months. While no parameter worsened over time, the moderately disabled MS cohort performed more poorly than the mildly disabled MS cohort who, in turn, was worse than control subjects for both objective and subjective walking and balance measures. Furthermore, the moderately disabled MS cohort demonstrated greater variation in between-visit performance than did the less disabled MS cohort or controls (Bonferroni-corrected p<0.05). Variability may be a key indicator of worsening gait and balance disability in MS.
步态和平衡缺陷是多发性硬化症(MS)患者常见的主诉,但秒表计时测试或评分量表难以准确捕捉这些问题。可穿戴式加速度计和陀螺仪能够检测出行走速度正常的MS患者的步态和平衡异常。很少有纵向研究使用这项技术来研究运动功能缺陷的演变。本研究的目的是确定可穿戴传感器是否能检测出MS患者的步态和平衡指标随时间的下降情况。27名行走速度正常的MS患者(13名轻度残疾,自我评定的扩展残疾状态量表评分为0 - 3.5;14名中度残疾,SR - EDSS评分为4.0 - 5.5)以及18名匹配的对照受试者,每6个月使用可穿戴传感器进行一次步态和平衡测试,共持续18个月。虽然没有参数随时间恶化,但中度残疾的MS队列在客观和主观的行走及平衡测量方面表现比轻度残疾的MS队列更差,而轻度残疾的MS队列又比对照受试者更差。此外,中度残疾的MS队列在各次访视之间的表现差异比残疾程度较轻的MS队列或对照组更大(经邦费罗尼校正,p<0.05)。变异性可能是MS患者步态和平衡残疾恶化的关键指标。